ZyVersa Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ZyVersa Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $-2.43 | $-3.70 | 34.3 % |
Jun 2024 | 2024-08-09 | $-3.31 | $-3.75 | 11.7 % |
Mar 2024 | 2024-05-15 | $-4.53 | $-3.70 | -22.4 % |
Dec 2023 | 2024-03-25 | $-0.25 | $-42.80 | 99.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
ZyVersa Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.
ZyVersa Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $-2.43, which beat the estimate of $-3.70.
ZyVersa Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.